Ming Zeng

机构：Sichuan Cancer Hospital, Jiangsu Province Hospital, Nanjing Medical University · ORCID：0000-0001-6387-546X

发表论文 74 篇 · 总被引 1595 次 · h-index 20

代表论文

• A novel anti-atherosclerotic mechanism of quercetin: Competitive binding to KEAP1 via Arg483 to inhibit macrophage pyroptosis (2022 · Redox Biology · 被引 138)
• Homocysteine promotes atherosclerosis through macrophage pyroptosis via endoplasmic reticulum stress and calcium disorder (2023 · Molecular Medicine · 被引 77)
• Estrogen deficiency accelerates postmenopausal atherosclerosis by inducing endothelial cell ferroptosis through inhibiting NRF2 / GPX4 pathway (2023 · The FASEB Journal · 被引 76)
• LncRNA KIAA0087 suppresses the progression of osteosarcoma by mediating the SOCS1/JAK2/STAT3 signaling pathway (2023 · Experimental & Molecular Medicine · 被引 51)
• Apigenin inhibits macrophage pyroptosis through regulation of oxidative stress and the NF‐κB pathway and ameliorates atherosclerosis (2023 · Phytotherapy Research · 被引 38)
• Clinical performance of a novel hybrid IVUS-OCT system: a multicentre, randomised, non-inferiority trial (PANOVISION) (2023 · EuroIntervention · 被引 18)